TABLE 5.
Strategy | Effects | Defect | Type of model | Refs |
---|---|---|---|---|
ADAM8 | Partial inhibition of ADAM8 protein hydrolysis may retard IDD | Only test a small fraction of genes | In vivo | Zhang et al. (2021) |
Bleomycin | Induction of cellular pro-fibrosis and maintain IVD height; Short-term application of bleomycin would not induce noticeable alterations in the cell cycle and apoptotic rate | — | In vivo | Yang et al. (2021) |
Low-loading hydrostatic pressure | Low-loading hydrostatic pressure facilitate to maintain cell survival and ECM homeostasis | Bioreactor pressure setting is not precise enough | In vitro | Wang et al. (2020) |
Low doses of short Link N | Inhibits cell death and promotes IVD synthesis ECM | — | In vivo | Mwale et al. (2018) |
Autologous PRP | Facilitates early recovery after injury | Need more studies and longer follow-up periods for evaluation | In vivo | Gelalis et al. (2019) |
Short-term continuous low-tension traction | Provides stable intervertebral environment; Inhibits ECM degradation; Reduces AF tension; Restores IVD height | Excessive traction time lead to IVD degeneration | In vivo | Che et al. (2019), Guo et al. (2020) |
PBM; Light-guided systems or photosensitizers | Downregulates MMP1 and MMP3 to restrain catabolism | Need more information on additional photoreceptors and effective doses before clinical application | In vitro | Hwang et al. (2020) |